Evaluating the Green Bay Packers roster entering the 2025 offseason. Who is under contract, a free agent, restructure options ...
Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.
Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback